Liver-spleen axis in nonalcoholic fatty liver disease

References

• Loomba R, Wong R, Fraysse J, et al. Nonalcoholic fatty liver disease progression rates to cir-rhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51(11):1149–1159.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Citro V, Capone D. Nonalcoholic fatty liver disease: a challenge from mecha-nisms to therapy. J Clin Med. 2020;9(1):15.
   Web of Science ®Google Scholar
• McPherson S, Hardy T, Henderson E, et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical man-agement. J Hepatol. 2015;62(5):1148–1155.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Baranova A, Ziegler K, et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology. 2005;42(3):665–674.
   PubMed Web of Science ®Google Scholar
• Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalco-holic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643–654.
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J. International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.
   PubMed Web of Science ®Google Scholar
• Mellinger JL, Pencina KM, Massaro JM, et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham heart study. J Hepatol. 2015;63(2):470–476.
   PubMed Web of Science ®Google Scholar
• Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of inci-dent acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. 2019;367:l5367.
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111–2117.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16(38):4773–4783.
   PubMed Web of Science ®Google Scholar
• Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–616.
   PubMed Web of Science ®Google Scholar
• Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4(33):eaau6085.
   PubMed Web of Science ®Google Scholar
• Dick R. The liver and spleen. In: Sutton D, editor. Text book of radiology and imaging. Lon-don: Churchill Livingstone; 1998. p. 981–1028.
   Google Scholar
• Yetter EM, Acosta KB, Olson MC, et al. Estimating splenic volume: sonographic meas-urements correlated with helical CT determination. AJR Am J Roentgenol. 2003;181(6):1615–1620.
   PubMed Web of Science ®Google Scholar
• Lamb PM, Lund A, Kanagasabay RR, et al. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assess-ments? Br J Radiol. 2002;75(895):573.
   PubMed Web of Science ®Google Scholar
• Klühs L, Teichgräber UK, Schneider U, et al. Accuracy of the so-nographic determination of the splenic weight in comparison with the weight at autopsy. Rofo. 2003;175(4):532–535.
   PubMedGoogle Scholar
• EhimwenmaO, Tagbo MT. Determination of normal dimension of the spleen by ultrasound in an endemic tropical environment. Niger Med J. 2011;52(3):198–203.
   PubMedGoogle Scholar
• Caglar V, Alkoc OA, Uygur R, et al. Determination of normal splenic volume in relation to age, gender and body habitus: a stereological study on computed tomography. Folia Morphol (Warsz). 2014;73(3):331–338.
   PubMed Web of Science ®Google Scholar
• Prassopoulos P, Daskalogiannaki M, Raissaki M, et al. Determination of normal splenic vol-ume on computed tomography in relation to age, gender and body habitus. Eur Radiol. 1997;7(2):246–248.
   PubMed Web of Science ®Google Scholar
• Ezeofor SN, Obikili EN. Anyanwu et al. Sonographic assessment of the normal limits of the spleen in healthy school children in South-East Nigeria. Niger J Clin Pract. 2014;17(4):484–488.
   PubMed Web of Science ®Google Scholar
• Chow KU, Luxembourg B, Seifried E, et al. Spleen size is significantly influenced by body height and sex: establishment of normal values for spleen size at US with a Cohort of 1200 healthy individuals. Radiology. 2016;279(1):306–313.
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci. 2000;45(1):196–200.
   PubMed Web of Science ®Google Scholar
• Sima HR, Desman GT, Azarian A, et al. Thickened abdominal subcutaneous adipose tissue and splenomegaly can differentiate steatohepatitis from steatosis: an autopsy study. Hepatol-ogy. 2008;48(4):814A–5A.
   Web of Science ®Google Scholar
• Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalco-holic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21(5):504–511.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Colicchio P, Conca P, et al. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm. 2009;6(6):6.
   Google Scholar
• Suzuki K, Kirikoshi H, Yoneda M, et al. Measurement of spleen volume is useful for distin-guishing between simple steatosis and early-stage non-alcoholic steatohepatitis. Hepatol Res. 2010;40(7):693–700.
   PubMed Web of Science ®Google Scholar
• Zardi EM, De Sio I, Ghittoni G, et al. Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis? J Clin Gastroenterol. 2011;45(1):59–63.
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Houlihan DD, Bentham L, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56(1):234–240.
   PubMed Web of Science ®Google Scholar
• Mendez FV, Suzuki A, Sanderson SO, et al. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013;10(9):1028–1033.
   Web of Science ®Google Scholar
• Kucybala I, Ciuk S, Tęczar J. Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen? Abdom Radiol (NY). 2018;43(9):2455–2461.
   PubMed Web of Science ®Google Scholar
• Bezerra AS, D’Ippolito G, Faintuch S, et al. Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol. 2005;184(5):1510–1513.
   PubMed Web of Science ®Google Scholar
• Abd El-Aziz RA, Naguib M, Rashed LA. Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters. Egypt J Intern Med. 2018;30(2):78–82.
   Google Scholar
• Item F, Konrad D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev. 2012;13(2):30–39.
   PubMedGoogle Scholar
• Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23(6):1042–1047.
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Papouchado BG, Li Z, et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103(6):1372–1379.
   PubMed Web of Science ®Google Scholar
• Mas E, Danjoux M, Garcia V, et al. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS One. 2009;4(11):e7929.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Citro V, Conforti P, et al. There a link between basal meta-bolic rate, spleen volume and hepatic growth factor levels in patients with obesity-related NAFLD? J Clin Med. 2019;8(10):1510.
   Web of Science ®Google Scholar
• Tarantino G, Marra M, Contaldo F, et al. Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. Clin Invest Med. 2008;31(1):E24–9.
   PubMed Web of Science ®Google Scholar
• Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806–818.
   PubMed Web of Science ®Google Scholar
• Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17(11–12):953–966.
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the devel-opment of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830.
   PubMed Web of Science ®Google Scholar
• Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538–1550.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Ackerman SE, Shen L, et al. Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest. 2017;27(1):5–13.
   Google Scholar
• Gerriets VA, MacIver NJ. Role of T cells in malnutrition and obesity. Front Immunol. 2014;5:379.
   PubMed Web of Science ®Google Scholar
• Mito N, Hosoda T, Kato C, et al. Change of cytokine balance in diet-induced obese mice. Me-tabolism. 2000;49(10):1295–1300.
   PubMed Web of Science ®Google Scholar
• Lee Y, Pham TX, Bae M, et al. Blackcurrant (ribes nigrum) prevents obesity-induced nonal-coholic steatohepatitis in mice. Obesity (Silver Spring). 2019;27(1):112–120.
   PubMed Web of Science ®Google Scholar
• He B, Wu L, Xie W, et al. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunol. 2017;18(1):33.
   PubMedGoogle Scholar
• Wu L, Parekh VV, Hsiao J, et al. Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance. Proc Natl Acad Sci U S A. 2014;111(43):E4638–47.
   PubMed Web of Science ®Google Scholar
• Baccan G, Hernández O, Díaz L, et al. Changes in lymphocyte subsets and functions in spleen from mice with high fat diet-induced obesity. Proc Nutr Soc. 2013;72(OCE1):E63.
   Web of Science ®Google Scholar
• Romano A, Hou X, Sertorio M, et al. FOXP3+ regulatory T cells in hepatic fibrosis and sple-nomegaly caused by schistosoma japonicum: the spleen may be a major source of tregs in subjects with splenomegaly. PLoS Negl Trop Dis. 2016;10(1):e0004306.
   PubMed Web of Science ®Google Scholar
• Deiuliis J, Shah Z, Shah N, et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One. 2011;6(1):e16376.
   PubMed Web of Science ®Google Scholar
• Ford WL, Gowans JL. The traffic of lymphocytes. Semin Hematol. 1969;6(1):67–83.
   PubMed Web of Science ®Google Scholar
• Torello CO, Paredes-Gamer EJ, Martins F, et al. Extramedular hematopoiesis in the spleen of obese mice modulation by the alga chlorella. Med Aromat Plants (Los Angel). 2016;5:275.
   Google Scholar
• Chauveau A, Pirgova G, Cheng HW, et al. Visualization of T cell migration in the spleen re-veals a network of perivascular pathways that guide entry into T zones. Immunity. 2020;52(5):794–807.
   PubMed Web of Science ®Google Scholar
• Altunkaynak BZ, Ozbek E, Altunkaynak ME. A stereological and histological analysis of spleen on obese female rats, fed with high fat diet. Saudi Med J. 2007;28(3):353–357.
   PubMed Web of Science ®Google Scholar
• da Silva AM, Corrêa CL, Neves RH, et al. A high-fat diet associated with acute schistosomiasis mansoni causes disorganization in splenic architecture in mice. Exp Parasitol. 2012;132(2):193–199.
   PubMed Web of Science ®Google Scholar
• Buchan L, St Aubin CR, Fisher AL, et al. High-fat, high-sugar diet induces splenomegaly that is ameliorated with exercise and genistein treatment. BMC Res Notes. 2018;11(1):752.
   PubMedGoogle Scholar
• Torres-Villalobos G, Hamdan-Pérez N, Tovar AR, et al. Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model. Ann Hepatol. 2015;14(4):540–546.
   PubMed Web of Science ®Google Scholar
• Gordon S, Plüddemann A, Mukhopadhyay S. Sinusoidal immunity: macrophages at the lym-phohematopoietic interface. Cold Spring Harb Perspect Biol. 2014;7(4):a016378.
   PubMed Web of Science ®Google Scholar
• Gotoh K, Inoue M, Masaki T, et al. A novel anti-inflammatory role for spleen-derived interleu-kin-10 in obesity-induced hypothalamic inflammation. J Neurochem. 2012;120(5):752–764.
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612–616.
   PubMed Web of Science ®Google Scholar
• Guareschi MZ, Marieli Ceglarek V, Rodrigues FP, et al. Exercise and vitamin D supplementa-tion modify spleen morphology in lean, but not, in monosodium-glutamate-obese rats. JSLR. 2019;1(3):15–17.
   Google Scholar
• Coelho C, França L, Nascimento J, et al. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice. J Dev Orig Health Dis. 2019;10(2):188–195.
   PubMed Web of Science ®Google Scholar
• Tsuneyama K, Nishida T, Baba H, et al. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. J Gas-troenterol Hepatol. 2014;29(9):1736–1743.
   PubMed Web of Science ®Google Scholar
• Polimeni L, Pastori D, Baratta F, et al. Spleen dimensions are inversely associated with lyso-somal acid lipase activity in patients with non-alcoholic fatty liver disease. Intern Emerg Med. 2017;12(8):1159–1165.
   PubMed Web of Science ®Google Scholar
• Bernstein DL, Hulkova H, Bialer MG, et al. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58(6):1230–1243.
   PubMed Web of Science ®Google Scholar
• de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97–105.
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB, Pitsavos C, Yannakoulia M, et al. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 2005;183(2):308e15.
   Web of Science ®Google Scholar
• Leite Nde C, Montes EG, Fisher SV, et al. Splenectomy attenuates obesity and decreases in-sulin hypersecretion in hypothalamic obese rats. Metabolism. 2015;64(9):1122–1133.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li N, Wang B, et al. Nonalcoholic fatty liver disease progression in rats is accelerated by splenic regulation of liver PTEN/AKT. Saudi J Gastroenterol. 2015;21(4):232–238.
   PubMed Web of Science ®Google Scholar
• Gotoh K, Inoue M, Masaki T, et al. A novel anti-inflammatory role for spleen-derived interleu-kin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes. 2012;61(8):1994–2003.
   PubMed Web of Science ®Google Scholar
• Hashem HE, Alazouny ZM. Does splenectomy modulate high fat diet induced liver injury in male rat? (histological and biochemical study). Br J Sci. 2016;13(2):45–58.
   Google Scholar
• Tarantino G, Scalera A, Finelli C. Liver‐spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol. 2013;9(23):3534–3542.
   Google Scholar
• Savastano S, Di Somma C, Pizza G, et al. Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med. 2011;9(1):136.
   PubMedGoogle Scholar
• Keramida G, Dunford A, Kaya G, et al. Hepato-splenic axis: he-patic and splenic metabolic activities are linked. Am J Nucl Med Mol Imaging. 2018;8(3):228–238.
   PubMed Web of Science ®Google Scholar
• Wang S, Cai B, Han X, et al. Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis. Medicine (Bal-timore). 2020;99(19):e,20148.
   Web of Science ®Google Scholar
• Abramovitch S, Dahan-Bachar L, Sharvit E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60(12):1728–1737.
   PubMed Web of Science ®Google Scholar
• Mohamed HK. Effect of vitamin D on the spleen of adult male rats fed on diet with high fat: a histological and immunohistochemical study. Egypt J Histol. 2019;42(4):1001–1017.
   Google Scholar
• Alzahrani KS, Nadeem A, Ahmad SF, et al. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. Biomed Pharmacother. 2019;111:347–358.
   PubMed Web of Science ®Google Scholar
• Balato N, Napolitano M, Ayala F, et al. Nonalcoholic fatty liver disease, spleen and psoriasis: new aspects of low-grade chronic inflammation. World J Gastroenterol. 2015;21(22):6892–6897.
   PubMed Web of Science ®Google Scholar
• Araújo NC. The spleen size in patients undergoing hemodialysi. J Bras Nefrol. 2021;43(1):61–67.
   PubMedGoogle Scholar
• Tarantino G, Vinciguerra M, Ragosta A, et al. Do transferrin levels predict haemodialysis ad-equacy in patients with end-stage renal disease? Nutrients. 2019;11(5):1123.
   Web of Science ®Google Scholar
• Platts MM, Anastassiades E, Sheriff S, et al. Spleen size in chronic renal failure. Br Med J (Clin Res Ed). 1984;289(6456):1415–1418.
   PubMedGoogle Scholar
• Targher G, Chonchol M, Zoppini G, et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol. 2011;54(5):1020–1029.
   PubMed Web of Science ®Google Scholar
• Capone D, Vinciguerra M, Ragosta A, et al. Troponin levels relate to crp re in patients with NAFLD on maintenance haemodialysis: a retrospective study. Adv Ther. 2020;37(7):3337–3347.
   PubMed Web of Science ®Google Scholar
• Gotoh K, Inoue M, Masaki T, et al. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrol Dial Transplant. 2013;8(5):1120–1130.
   Google Scholar
• Zheng Z, Xu X, Zhang X, et al. Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J Hepatol. 2013;58(1):148–154.
   PubMed Web of Science ®Google Scholar
• Goldberg GM. The impregnation of the human spleen by particulate matter. A study of lym-phogenic and hematogenic “involvement patterns” of the spleen. Am J Clin Pathol. 1961;35(4):328–337.
   PubMed Web of Science ®Google Scholar
• Jin R, Jin X, Lyu L, et al. The potential immunotoxicity of fine particulate matter based on SD rat spleen. Environ Sci Pollut Res Int. 2019;26(23):23958–23966.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Capone D, Finelli C. Exposure to ambient air particulate matter and non-alcoholic fatty liver disease. World J Gastroenterol. 2013;19(25):3951–3956.
   PubMed Web of Science ®Google Scholar
• Wu J, Yao XY, Shi RX, et al. A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis. Reprod Health. 2018;15(1):77.
   PubMedGoogle Scholar
• Tarantino G, Valentino R, Di Somma C, et al. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf). 2013;78(3):447–453.
   PubMed Web of Science ®Google Scholar
• Paschetta E, Belci P, Alisi A, et al. OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. Mediators Inflamm. 2015;815721:2015.
   Google Scholar
• Koella WP. Serotonin and sleep. Exp Med Surg. 1969;27(1–2):157–169.
   PubMedGoogle Scholar
• Heyssel RM, Silver LJ, Wasson M, et al. The relation of blood platelet survival and distribu-tion to 14C-serotonin distribution and excretion. Blood. 1967;29(3):341–353.
   PubMed Web of Science ®Google Scholar
• Iken K, Chheng S, Fargin A, et al. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol. 1995;163(1):1–9.
   PubMed Web of Science ®Google Scholar
• Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr. 2008;32(6):638–644.
   PubMed Web of Science ®Google Scholar
• Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the met-abolic syndrome. J Am Coll Cardiol. 2006;48(4):677–685.
   PubMed Web of Science ®Google Scholar
• Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006;91(12):4753–4761.
   PubMed Web of Science ®Google Scholar
• Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):179–185.
   PubMed Web of Science ®Google Scholar
• Akhtar A. The flaws and human harms of animal experimentation. Camb Q Healthc Ethics. 2015;24(4):407–419.
   PubMed Web of Science ®Google Scholar
• Lamas O, Martínez JA, Marti A. Decreased splenic mRNA expression levels of TNF-alpha and IL-6 in diet-induced obese animals. J Physiol Biochem. 2004;60(4):279–283.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Jin Y, et al. Splenectomy leads to amelioration of altered gut microbiota and metabolome in liver cirrhosis patients. Front Microbiol. 2018;9:963.
   PubMed Web of Science ®Google Scholar
• Barrea L, Di Somma C, Muscogiuri G, et al. Nutrition, inflammation and liver-spleen axis. Crit Rev Food Sci Nutr. 2018;58(18):3141–3158.
   PubMed Web of Science ®Google Scholar
• Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–1090.
   PubMed Web of Science ®Google Scholar